nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.176	0.26	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.176	0.26	CbGbCtD
Imipramine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.107	0.157	CbGbCtD
Imipramine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0859	0.127	CbGbCtD
Imipramine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.081	0.12	CbGbCtD
Imipramine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0515	0.0761	CbGbCtD
Imipramine—SLC22A2—nephron—focal segmental glomerulosclerosis	0.0233	0.188	CbGeAlD
Imipramine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0186	0.15	CbGeAlD
Imipramine—HTR7—endothelium—focal segmental glomerulosclerosis	0.00613	0.0494	CbGeAlD
Imipramine—KCND3—cortex of kidney—focal segmental glomerulosclerosis	0.00606	0.0489	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00521	0.042	CbGeAlD
Imipramine—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.00503	0.0406	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00446	0.036	CbGeAlD
Imipramine—SLC22A2—kidney—focal segmental glomerulosclerosis	0.00442	0.0357	CbGeAlD
Imipramine—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.00431	0.0347	CbGeAlD
Imipramine—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.0377	CcSEcCtD
Imipramine—ADRA1B—kidney—focal segmental glomerulosclerosis	0.00423	0.0341	CbGeAlD
Imipramine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00382	0.0308	CbGeAlD
Imipramine—SLC22A4—nephron tubule—focal segmental glomerulosclerosis	0.00373	0.0301	CbGeAlD
Imipramine—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.0314	CcSEcCtD
Imipramine—SLC22A4—kidney—focal segmental glomerulosclerosis	0.00328	0.0265	CbGeAlD
Imipramine—SLC22A4—cortex of kidney—focal segmental glomerulosclerosis	0.00319	0.0258	CbGeAlD
Imipramine—SLC22A1—kidney—focal segmental glomerulosclerosis	0.00312	0.0252	CbGeAlD
Imipramine—SLC22A3—kidney—focal segmental glomerulosclerosis	0.00299	0.0241	CbGeAlD
Imipramine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.0244	CcSEcCtD
Imipramine—CHRM3—kidney—focal segmental glomerulosclerosis	0.00259	0.0209	CbGeAlD
Imipramine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.0226	CcSEcCtD
Imipramine—Benazepril—ACE—focal segmental glomerulosclerosis	0.00252	0.385	CrCbGaD
Imipramine—HTR7—kidney—focal segmental glomerulosclerosis	0.00247	0.0199	CbGeAlD
Imipramine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.0205	CcSEcCtD
Imipramine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.0205	CcSEcCtD
Imipramine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.0197	CcSEcCtD
Imipramine—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0196	CcSEcCtD
Imipramine—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0194	CcSEcCtD
Imipramine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.019	CcSEcCtD
Imipramine—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.00214	0.0173	CbGeAlD
Imipramine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.0188	CcSEcCtD
Imipramine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.0182	CcSEcCtD
Imipramine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.018	CcSEcCtD
Imipramine—CYP2E1—nephron tubule—focal segmental glomerulosclerosis	0.00201	0.0162	CbGeAlD
Imipramine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.0173	CcSEcCtD
Imipramine—CYP2B6—kidney—focal segmental glomerulosclerosis	0.00188	0.0152	CbGeAlD
Imipramine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0165	CcSEcCtD
Imipramine—CYP2E1—kidney—focal segmental glomerulosclerosis	0.00177	0.0143	CbGeAlD
Imipramine—CYP2E1—cortex of kidney—focal segmental glomerulosclerosis	0.00172	0.0139	CbGeAlD
Imipramine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0146	CcSEcCtD
Imipramine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0144	CcSEcCtD
Imipramine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0143	CcSEcCtD
Imipramine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0141	CcSEcCtD
Imipramine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0141	CcSEcCtD
Imipramine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0139	CcSEcCtD
Imipramine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0138	CcSEcCtD
Imipramine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0138	CcSEcCtD
Imipramine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0138	CcSEcCtD
Imipramine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0138	CcSEcCtD
Imipramine—HTR2A—kidney—focal segmental glomerulosclerosis	0.00154	0.0124	CbGeAlD
Imipramine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0133	CcSEcCtD
Imipramine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0127	CcSEcCtD
Imipramine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0126	CcSEcCtD
Imipramine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00142	0.0115	CbGeAlD
Imipramine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0125	CcSEcCtD
Imipramine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0124	CcSEcCtD
Imipramine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.0014	0.0113	CbGeAlD
Imipramine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.0118	CcSEcCtD
Imipramine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0118	CcSEcCtD
Imipramine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0115	CcSEcCtD
Imipramine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0114	CcSEcCtD
Imipramine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0113	CcSEcCtD
Imipramine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0112	CcSEcCtD
Imipramine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0111	CcSEcCtD
Imipramine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.011	CcSEcCtD
Imipramine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0108	CcSEcCtD
Imipramine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0108	CcSEcCtD
Imipramine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0107	CcSEcCtD
Imipramine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0104	CcSEcCtD
Imipramine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.0103	CcSEcCtD
Imipramine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0102	CcSEcCtD
Imipramine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0101	CcSEcCtD
Imipramine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00115	0.00925	CbGeAlD
Imipramine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00994	CcSEcCtD
Imipramine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00987	CcSEcCtD
Imipramine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00955	CcSEcCtD
Imipramine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00952	CcSEcCtD
Imipramine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00935	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00932	CcSEcCtD
Imipramine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00927	CcSEcCtD
Imipramine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00918	CcSEcCtD
Imipramine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00907	CcSEcCtD
Imipramine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.009	CcSEcCtD
Imipramine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.009	CcSEcCtD
Imipramine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00894	CcSEcCtD
Imipramine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00101	0.00813	CbGeAlD
Imipramine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00882	CcSEcCtD
Imipramine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000999	0.00881	CcSEcCtD
Imipramine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000991	0.00874	CcSEcCtD
Imipramine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000986	0.0087	CcSEcCtD
Imipramine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000981	0.00791	CbGeAlD
Imipramine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000972	0.00858	CcSEcCtD
Imipramine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000923	0.00814	CcSEcCtD
Imipramine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000916	0.00808	CcSEcCtD
Imipramine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000907	0.008	CcSEcCtD
Imipramine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000898	0.00792	CcSEcCtD
Imipramine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000887	0.00782	CcSEcCtD
Imipramine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000881	0.00777	CcSEcCtD
Imipramine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00088	0.00776	CcSEcCtD
Imipramine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000872	0.00769	CcSEcCtD
Imipramine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000841	0.00741	CcSEcCtD
Imipramine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000834	0.00736	CcSEcCtD
Imipramine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00081	0.00715	CcSEcCtD
Imipramine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00711	CcSEcCtD
Imipramine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00711	CcSEcCtD
Imipramine—Oxcarbazepine—ALB—focal segmental glomerulosclerosis	0.000784	0.12	CrCbGaD
Imipramine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000732	0.00646	CcSEcCtD
Imipramine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000722	0.00637	CcSEcCtD
Imipramine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000698	0.00616	CcSEcCtD
Imipramine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000675	0.00595	CcSEcCtD
Imipramine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000649	0.00572	CcSEcCtD
Imipramine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000643	0.00567	CcSEcCtD
Imipramine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000643	0.00567	CcSEcCtD
Imipramine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000639	0.00564	CcSEcCtD
Imipramine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00534	CcSEcCtD
Imipramine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.000593	0.0905	CrCbGaD
Imipramine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.000579	0.0884	CrCbGaD
Imipramine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.00057	0.087	CrCbGaD
Imipramine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.00045	0.0688	CrCbGaD
Imipramine—Nortriptyline—ALB—focal segmental glomerulosclerosis	0.00044	0.0672	CrCbGaD
Imipramine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.000309	0.0472	CrCbGaD
Imipramine—Amitriptyline—ALB—focal segmental glomerulosclerosis	0.000305	0.0466	CrCbGaD
Imipramine—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.51e-05	0.000445	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.5e-05	0.000443	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.49e-05	0.000441	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.47e-05	0.000439	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.47e-05	0.000439	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.47e-05	0.000438	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.46e-05	0.000437	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.45e-05	0.000436	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.44e-05	0.000436	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.42e-05	0.000432	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.41e-05	0.000431	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CTGF—focal segmental glomerulosclerosis	3.41e-05	0.000431	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.4e-05	0.00043	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.4e-05	0.00043	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.34e-05	0.000423	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.34e-05	0.000422	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.33e-05	0.000421	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.32e-05	0.00042	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.26e-05	0.000412	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.23e-05	0.000408	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.22e-05	0.000407	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.21e-05	0.000407	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.21e-05	0.000406	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.21e-05	0.000405	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.2e-05	0.000405	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.18e-05	0.000402	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.18e-05	0.000402	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.17e-05	0.000401	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.17e-05	0.0004	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.16e-05	0.0004	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.16e-05	0.000399	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.15e-05	0.000398	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.15e-05	0.000398	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.15e-05	0.000398	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.14e-05	0.000397	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.14e-05	0.000397	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.14e-05	0.000397	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.13e-05	0.000396	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.12e-05	0.000395	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.12e-05	0.000394	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.11e-05	0.000394	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.11e-05	0.000393	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.11e-05	0.000393	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.11e-05	0.000393	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.1e-05	0.000392	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.09e-05	0.000391	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.08e-05	0.00039	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.06e-05	0.000387	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.05e-05	0.000385	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.03e-05	0.000383	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.95e-05	0.000373	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.95e-05	0.000373	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.95e-05	0.000373	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.94e-05	0.000371	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.93e-05	0.000371	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.93e-05	0.000371	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.92e-05	0.000369	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.9e-05	0.000367	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000365	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000364	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—ALB—focal segmental glomerulosclerosis	2.87e-05	0.000363	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.87e-05	0.000363	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.87e-05	0.000363	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.86e-05	0.000362	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.83e-05	0.000358	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.82e-05	0.000357	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.81e-05	0.000356	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.8e-05	0.000354	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.79e-05	0.000353	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.78e-05	0.000352	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.75e-05	0.000347	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.74e-05	0.000347	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.73e-05	0.000345	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—ALB—focal segmental glomerulosclerosis	2.71e-05	0.000343	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.7e-05	0.000341	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.69e-05	0.00034	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.69e-05	0.00034	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.67e-05	0.000337	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.66e-05	0.000337	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.66e-05	0.000337	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.66e-05	0.000336	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.65e-05	0.000335	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.64e-05	0.000334	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.64e-05	0.000334	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.64e-05	0.000334	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.63e-05	0.000333	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.62e-05	0.000332	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.6e-05	0.000329	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.59e-05	0.000328	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	2.56e-05	0.000323	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	2.51e-05	0.000318	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.51e-05	0.000318	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.5e-05	0.000317	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.46e-05	0.000311	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.46e-05	0.000311	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.46e-05	0.000311	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.45e-05	0.00031	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.42e-05	0.000306	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.42e-05	0.000305	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.41e-05	0.000304	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.41e-05	0.000304	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.4e-05	0.000304	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.38e-05	0.000301	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.38e-05	0.0003	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.37e-05	0.0003	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.36e-05	0.000299	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	2.36e-05	0.000299	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	2.35e-05	0.000297	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.35e-05	0.000297	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.32e-05	0.000294	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.31e-05	0.000293	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.3e-05	0.000291	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.3e-05	0.000291	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.29e-05	0.00029	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.26e-05	0.000286	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.26e-05	0.000286	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.26e-05	0.000286	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.22e-05	0.000281	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	2.21e-05	0.00028	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.19e-05	0.000278	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	2.19e-05	0.000277	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.18e-05	0.000276	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.17e-05	0.000275	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.16e-05	0.000273	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.1e-05	0.000266	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.09e-05	0.000264	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.09e-05	0.000264	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.08e-05	0.000263	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.05e-05	0.00026	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.05e-05	0.000259	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.05e-05	0.000259	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.05e-05	0.000259	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.04e-05	0.000258	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.04e-05	0.000258	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.04e-05	0.000258	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.03e-05	0.000257	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	2.03e-05	0.000257	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.02e-05	0.000256	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	2.02e-05	0.000255	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.01e-05	0.000255	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.01e-05	0.000254	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.99e-05	0.000252	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.99e-05	0.000252	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	1.99e-05	0.000252	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.99e-05	0.000251	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.98e-05	0.00025	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.97e-05	0.00025	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.97e-05	0.000249	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.96e-05	0.000248	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.96e-05	0.000248	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.95e-05	0.000247	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.95e-05	0.000247	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.93e-05	0.000244	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.92e-05	0.000242	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.89e-05	0.000238	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.88e-05	0.000238	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.88e-05	0.000237	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.88e-05	0.000237	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.88e-05	0.000237	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.87e-05	0.000236	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.85e-05	0.000234	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.85e-05	0.000234	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.85e-05	0.000234	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.82e-05	0.00023	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.81e-05	0.000229	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.8e-05	0.000228	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.8e-05	0.000228	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.76e-05	0.000223	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.74e-05	0.00022	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	1.74e-05	0.00022	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.73e-05	0.000219	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.73e-05	0.000219	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.73e-05	0.000218	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.7e-05	0.000215	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	1.7e-05	0.000215	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.7e-05	0.000215	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.69e-05	0.000214	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.69e-05	0.000214	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.68e-05	0.000212	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.67e-05	0.000212	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.67e-05	0.000211	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.6e-05	0.000202	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.59e-05	0.000201	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.57e-05	0.000199	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.57e-05	0.000199	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.57e-05	0.000198	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.57e-05	0.000198	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.57e-05	0.000198	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.56e-05	0.000197	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	1.55e-05	0.000196	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.55e-05	0.000195	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.54e-05	0.000195	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.53e-05	0.000194	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.52e-05	0.000192	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.51e-05	0.000191	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.51e-05	0.000191	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.5e-05	0.000189	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.48e-05	0.000187	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.44e-05	0.000183	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.42e-05	0.000179	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.41e-05	0.000179	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	1.33e-05	0.000169	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.33e-05	0.000168	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.33e-05	0.000168	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.33e-05	0.000168	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.31e-05	0.000166	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.31e-05	0.000166	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.31e-05	0.000165	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	1.31e-05	0.000165	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.3e-05	0.000165	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.3e-05	0.000164	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.29e-05	0.000164	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.29e-05	0.000163	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.29e-05	0.000163	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.28e-05	0.000162	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.28e-05	0.000162	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.23e-05	0.000155	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.22e-05	0.000154	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.21e-05	0.000153	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.2e-05	0.000151	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.17e-05	0.000148	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.16e-05	0.000147	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.16e-05	0.000146	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.11e-05	0.00014	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.1e-05	0.000139	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.02e-05	0.000129	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.02e-05	0.000129	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.01e-05	0.000127	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1e-05	0.000127	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1e-05	0.000127	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.98e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.95e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.85e-06	0.000125	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	9.83e-06	0.000124	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.82e-06	0.000124	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.57e-06	0.000121	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.52e-06	0.00012	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	9.27e-06	0.000117	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	9.23e-06	0.000117	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.11e-06	0.000115	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.4e-06	0.000106	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.27e-06	0.000105	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.25e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.22e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.2e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.12e-06	0.000103	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.1e-06	0.000102	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	7.9e-06	9.99e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	7.85e-06	9.93e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.06e-06	7.66e-05	CbGpPWpGaD
